SMTL ID : 5ote.1

MRCK beta in complex with BDP-00008900

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.68 Å

Oligo State

homo-dimer

Ligands

2 x AQE: 2-[4-[(6~{S})-1,8-diazaspiro[5.5]undecan-8-yl]-1~{H}-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole(Non-covalent)

AQE.1: 13 residues within 4Å: Chain A: I.84, V.92, A.105, K.107, M.155, D.156, Y.157, Y.158, D.206, N.207, L.209, A.219, F.372 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:I.84, A:F.372 Hydrogen bonds: A:D.156, A:Y.158 Water bridges: A:D.220 AQE.4: 13 residues within 4Å: Chain B: I.84, V.92, A.105, K.107, M.155, D.156, Y.157, Y.158, D.206, N.207, L.209, A.219, F.372 5 PLIP interactions: 5 interactions with chain B Hydrophobic interactions: B:I.84, B:F.372 Hydrogen bonds: B:D.156, B:Y.158 Water bridges: B:D.220

2 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 5 residues within 4Å: Chain A: G.392, F.393 Chain B: G.392, F.393 Ligands: CL.5 Ligand excluded by PLIP CL.5: 5 residues within 4Å: Chain A: G.392, F.393 Chain B: G.392, F.393 Ligands: CL.2 Ligand excluded by PLIP

2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.3: 7 residues within 4Å: Chain A: K.107, L.109, A.121, C.122, F.123, E.126, G.222 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:K.107, A:K.107, A:T.120, A:C.122 EDO.6: 7 residues within 4Å: Chain B: K.107, L.109, A.121, C.122, F.123, E.126, G.222 4 PLIP interactions: 4 interactions with chain B Hydrogen bonds: B:K.107, B:K.107, B:T.120, B:C.122

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Unbekandt, M. et al., Discovery of Potent and Selective MRCK Inhibitors with Therapeutic Effect on Skin Cancer. Cancer Res. (2018)

Release Date

2018-02-21

Peptides

Serine/threonine-protein kinase MRCK beta: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

Serine/threonine-protein kinase MRCK beta

Related Entries With Identical Sequence